Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution

Area of Science:

• Neuroscience
• Biochemistry
• Structural Biology

Background:

• Amyloid beta (Aβ) oligomers are implicated in Alzheimer's disease neurodegeneration.
• The precise structural characteristics of these oligomers remain poorly understood.
• Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain.

Purpose of the Study:

• To identify and characterize the small oligomeric species of amyloid beta 42 (Aβ42) in solution.
• To investigate the structural properties of Aβ42 oligomers using biophysical and computational methods.
• To determine the lower limit of detectable Aβ42 oligomer size.

Main Methods:

• Sedimentation velocity centrifugation.
• Small-angle neutron scattering (SANS) for structural analysis.
• Molecular dynamics (MD) simulations for structural modeling.

Main Results:

• Identified Aβ42 oligomers with a sedimentation coefficient of 2.56 S and a radius of gyration between 2-4 nm.
• Smallest detectable species were penta- to hexamers.
• No evidence for the presence of dimers, trimers, or tetramers at measurable quantities.

Conclusions:

• The smallest amyloid beta 42 oligomers in solution are penta- to hexamers.
• Findings challenge previous reports suggesting the presence of smaller oligomeric species.
• This study provides novel insights into Aβ42 oligomer structure, crucial for understanding Alzheimer's disease pathogenesis.